Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Aging01:26

Aging

849
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
849
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.7K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

232
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
232
Mitochondria01:37

Mitochondria

20.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Associations between Biomarkers of Vitamin B<sub>12</sub> Status and Gut Microbial Guilds in a Cohort of Australian Adults.

The Journal of nutrition·2026
Same author

Two stable gut microbiome guilds predict liver tumor class and treatment responses.

iMeta·2026
Same author

Plant-based enteral nutrition outperforms ultra-processed formulas in mitigating consequences of antibiotic-induced dysbiosis.

JCI insight·2026
Same author

Intestinal stearoyl-CoA desaturase-2 is highly expressed and nutritionally regulated but dispensable for energy balance.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2026
Same author

Dietary fiber fermentation restores microbiome resilience to oxygen stress in a host-independent <i>ex vivo</i> model.

mBio·2026
Same author

Dietary animal fat disrupts gut microbiota and aggravates Scl-cGVHD after allogeneic hematopoietic stem cell transfer.

Blood advances·2026

関連する実験動画

Updated: Feb 17, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

4.1K

腎臓の老化:研究モデル,介入,開発トレンド

Yongpan An1, Ruixiao Li2, Rui Zhang3

  • 1Department of Urology, Xi'an People's Hospital (Xi'an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi'an, Shaanxi 710199, China; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, Shaanxi, China.

Drug discovery today
|February 15, 2026
PubMed
まとめ
この要約は機械生成です。

腎臓の老化は,特に高齢者の場合,損傷と病気につながる. このレビューは,老化による腎臓の変化,老化モデル,そして,よりよい腎臓の健康のために老化を遅らせる戦略を網羅しています.

キーワード:
介入・介入は,介入によるものです.腎臓老化のモデル腎臓の老化は

さらに関連する動画

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
06:18

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans

Published on: April 13, 2018

6.4K
Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

5.9K

関連する実験動画

Last Updated: Feb 17, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

4.1K
Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
06:18

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans

Published on: April 13, 2018

6.4K
Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
07:04

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

5.9K

科学分野:

  • ネフロロジーは腎臓科です.
  • ゲロントロジーはゲロントロジーの学科です.
  • 分子生物学は分子生物学である.

背景:

  • 老化した腎臓は損傷を受けやすく,腎臓疾患の危険因子です.
  • 高齢者の慢性腎臓病は,世界的な健康上の懸念が高まっています.
  • 腎臓の老化の分子および細胞メカニズムを理解するうえでの進歩は極めて重要です.

研究 の 目的:

  • 老化中の腎臓の病理学的変化を要約すると.
  • 腎老化の疾患モデルを調査する.
  • 腎臓の老化を遅らせるための潜在的な戦略を見直す.

主な方法:

  • 老化中の腎臓の病理学的変化に関する文献レビュー.
  • 腎老化疾患モデルの体系的な調査.
  • 腎臓の老化を遅らせるための潜在的な介入の分析.

主要な成果:

  • 腎臓の構造と機能における年齢に関連する病理学的変化の詳細な説明.
  • 腎臓の老化を研究するための既定および新興モデルの概要.
  • 腎臓の老化を緩和するための治療目標と戦略の特定.

結論:

  • 腎臓の老化メカニズムを理解することは,年齢に関連する腎臓疾患の予防の鍵です.
  • 病気のモデルは,老化と潜在的な介入に関する洞察を提供します.
  • 腎臓の老化を遅らせる戦略は,将来の研究と臨床実践のための理論的基礎を提供します.